Literature DB >> 18770031

Prevalence and importance of amebic infestation in patients with ulcerative colitis in two regions in Turkey.

Aliye Soylu1, Can Dolapcioglu, Halil Alis, Kemal Dolay, Nurgul Yasar, Omer Boduroglu, Aydin Cildas, Fusun F Bolukbas, Cengiz Bolukbas.   

Abstract

We investigated the prevalence of amebiasis in patients with ulcerative colitis residing in two geographical regions with different socioeconomic status and climatic conditions, and its effect on the age of onset, duration, localization, and activity of disease. Ninety patients from a high socioeconomic location (group I) and 28 cases from a low socioeconomic location (group II) were enrolled. Median age at disease onset was significantly higher in group I compared with in group II. Prevalence of amebiasis in group I was significantly lower than in group II. A considerably number of patients with amebiasis in group I had a history of travel to the cities with a lower socioeconomic level, mainly located in the east of Turkey. There was a strong relationship between presence of amebiasis and history of travel to eastern parts of Turkey among residents from the northwestern part of Turkey. Median age and age at time of diagnosis were significantly lower in patients with amebiasis compared with those without infection. In patients with mild disease activity, prevalence of amebiasis was significantly lower compared with those with moderate or severe disease activity. In conclusion, prevalence of amebiasis was markedly higher in the southeast compared to the northwest of Turkey. Travel to regions with low socioeconomic status may be considered a risk factor for amebiasis in patients with ulcerative colitis. Amebiasis enhances disease activity in ulcerative colitis.

Entities:  

Mesh:

Year:  2008        PMID: 18770031     DOI: 10.1007/s10620-008-0488-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Amebic colitis simulating ulcerative colitis.

Authors:  R Ebecken
Journal:  Gastrointest Endosc       Date:  2000-05       Impact factor: 9.427

2.  Environmental pollution with soil-transmitted helminths in Sanliurfa, Turkey.

Authors:  M Ulukanligil; A Seyrek; G Aslan; H Ozbilge; S Atay
Journal:  Mem Inst Oswaldo Cruz       Date:  2001-10       Impact factor: 2.743

3.  Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.

Authors:  Siew C Ng; Naila Arebi; Michael A Kamm
Journal:  Inflamm Bowel Dis       Date:  2007-02       Impact factor: 5.325

Review 4.  Diagnosis of invasive amoebiasis--time to end the morphology era.

Authors:  J I Ravdin
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

5.  [Amoebiasis--a problem in patients with ulcerative colitis].

Authors:  D Prokopowicz; K Zagórski; P Kramarz
Journal:  Wiad Lek       Date:  1994-04

6.  Gender distribution in asymptomatic and invasive amebiasis.

Authors:  R Acuna-Soto; J H Maguire; D F Wirth
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

Review 7.  Amoebiasis.

Authors:  Samuel L Stanley
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

Review 8.  [Amebiasis].

Authors:  P L Andersen
Journal:  Ugeskr Laeger       Date:  2000-03-13

9.  Nondysenteric intestinal amebiasis. Colonic morphology and search for Entamoeba histolytica adherence and invasion.

Authors:  E P Variyam; P Gogate; M Hassan; W J Costerton; S Pillai; H Ward; K Jalan
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

10.  Amebic colitis mistaken for inflammatory bowel disease.

Authors:  P C Tucker; P D Webster; Z M Kilpatrick
Journal:  Arch Intern Med       Date:  1975-05
View more
  2 in total

1.  Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

Authors:  Maria Esteve; Carme Loras; Ester García-Planella
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

2.  Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey.

Authors:  Madunil A Niriella; Arjuna P De Silva; Asangi H G K Dayaratne; Madurangi H A D P Ariyasinghe; Metthanandha M N Navarathne; Ranjith S K Peiris; D Nandadeva Samarasekara; Raveendra L Satharasinghe; Sharman Rajindrajith; Anuradha S Dassanayake; A Rajitha Wickramasinghe; H Janaka de Silva
Journal:  BMC Gastroenterol       Date:  2010-03-19       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.